SAS and Carolina partner to accelerate antiviral drug development

Posted Nov 19, 2021
SAS, a leader in analytics and software services, and the University of North Carolina are teaming up to transform the drug development process to prevent infectious disease threats from turning into a pandemic like COVID-19. The partnership is focused on the work of the University’s Rapidly Emerging Antiviral Drug Development Initiative (READDI). (UNC.edu)

Related: Campus Connections

UNC football optimism flows - along with the beer - as Tar Heels take Dublin
It started out as a means of following a country star. Well, Chase Rice wasn’t a country star yet when Sophie Watkeys, 32, first started...
Wed Sep 2, 2026

UNC Libraries is Home to a Special Dolly Parton Recording. Here’s What to Know
People across the United States and around the world are mourning country music legend and philanthropist Dolly Parton, who died on Tuesday at 80 years...
Mon Aug 31, 2026

The Emerald Isle now touched with Carolina Blue
University of North Carolina at Chapel Hill chancellor Lee H. Roberts looked around in wonder at the sanctuary of the 800-year-old St. Patrick’s Cathedral in...
Sun Aug 30, 2026

Merritt’s Grill Opening Second Location in Chapel Hill; Einstein Bros. Bagels Opening First
Merritt’s Grill, whose BLT sandwiches have been a staple of the Chapel Hill, North Carolina culinary scene since the restaurant opened in 1992, is opening...
Sat Aug 29, 2026